BCBS North Dakota Medical Policy Updates – December 2022

Click here to view the Blue Cross Blue Shield BCBS North Dakota Medical Policy Updates »

December 2022 BCBS North Dakota Medical Policy Updates:

• Abatacept (Orencia)
• Abatacept (Orencia) IV (Medicaid Expansion)
• Aducanumab-avwa (Aduhelm) (Medicaid Expansion)
• Alemtuzumab (Lemtrada) (Medicaid Expansion)
• Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemia
• Apos Therapy System
• Burosumab (Crysvita) (Medicaid Expansion)
• Casimersen (Amondys-45) (Medicaid Expansion)
• Cerliponase Alfa (Brineura) (Medicaid Expansion)
• Corneal Transplantation
• Diabetic Services and Supplies
• Diagnosis and Treatment of Sacroiliac Joint Pain
• Drug Testing
• Edaravone (Radicava) (Medicaid Expansion)
• Elosulfase alfa (Vimizim) (Medicaid Expansion)
• Emapalumab-lzsg (Gamifant) (Medicaid Expansion)
• Eptinezumab-jjmr (Vyepti) (Medicaid Expansion)
• Evinacumab-dgnb (Evkeeza) (Medicaid Expansion)
• Exondys 51 (eteplirsen) (Medicaid Expansion)
• Experimental/Investigational
• Galsulfase (Naglazyme) (Medicaid Expansion)
• Givosiran (Givlaari) (Medicaid Expansion)
• Granulocyte Colony-Stimulating Factors
• Hydroxyprogesterone Caproate Injection as a Technique to Reduce Preterm Birth in High-Risk Pregnancies (Medicaid Expansion)
• Idursulfase (Elaprase) (Medicaid Expansion)
• IL-1 and IL-1b Blockers
• Inebilizumab-cdon (Uplizna) (Medicaid Expansion)
• Laronidase (Aldurazyme) (Medicaid Expansion)
• Lumasiran (Oxlumo) (Medicaid Expansion)
• Lung and Lobar Lung Transplantation
• Luspatercept (Reblozyl) (Medicaid Expansion)
• Magnetic Esophageal Ring to Treat Gastroesophageal Reflux Disease (LINX®)
• Medications and Diabetic Supplies Payable on the Pharmacy Benefit (Medicaid Expansion)
• Meniscal Allografts and Other Meniscal Implants
• Monoclonal Antibodies for the Treatment of Eosinophilic Conditions
• Natalizumab (Tysabri) (Medicaid Expansion)
• Necitumumab (Portrazza)
• Nusinersen (Spinraza) (Medicaid Expansion)
• Ocrelizumab (Ocrevus) (Medicaid Expansion)
• Pegcetacoplan (Empaveli)
• Pegloticase (Krystexxa) (Medicaid Expansion)
• Powered Exoskeletal Robotic Systems
• romiplostim (Nplate)
• romiplostim (Nplate)
• Sebelipase alfa (Kanuma) (Medicaid Expansion)
• Teprotumumab-trbw (Tepezza) (Medicaid Expansion)
• Tildrakizumab-asmn (Ilumya)
• Tocilizumab (Actemra)
• Treatment of Benign or Premalignant Skin Conditions
• Treatment of Gaucher Disease (Medicaid Expansion)
• Treatment of Hereditary Amyloidosis (Medicaid Expansion)
• Treatment of Malignant Skin Lesions
• Ultraviolet Light Therapies
• Ustekinumab (Stelara®) IV
• Vedolizumab (Entyvio)
• Vestronidase alfa-vjbk (Mepsevii) (Medicaid Expansion)
• Viltolarsen (Viltepso) (Medicaid Expansion)
• Voretigene Neparvovec-rzyl (Luxturna) (Medicaid Expansion)

Click here to view the Blue Cross Blue Shield BCBS North Dakota Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.